Related Articles Even Market-Neutral Funds Couldn’t Escape the AI Slump in October Julie Segal It’s Biopharma or Bust for the IPO Market Stephen Taub When Collateral Matters: Why Commercial Real Estate Debt Stands Apart in Private Credit Sponsored by Heitman